Covered recipient · General Payments record
MARY E MCNEER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,303.53
- Reported across 85 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $271.38 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $103.46 | 6 |
| Astellas Pharma US Inc | $40.39 | 2 |
| PFIZER INC. | $34.56 | 2 |
| Acerta Pharma LLC | $29.43 | 2 |
| Lilly USA, LLC | $27.62 | 2 |
| Sumitomo Pharma America, Inc. | $18.06 | 1 |
| ABBVIE INC. | $17.86 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.86 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107641556 | CMS |
| Astellas Pharma US Inc | $23.07 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139502997 | CMS |
| Astellas Pharma US Inc | $17.32 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139559007 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.08 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105663798 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.35 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105769794 | CMS |
| Lilly USA, LLC | $13.47 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135778962 | CMS |
| Lilly USA, LLC | $14.15 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135816512 | CMS |
| Novo Nordisk Inc | $15.94 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100590816 | CMS |
| Novo Nordisk Inc | $17.19 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100425984 | CMS |
| Novo Nordisk Inc | $17.11 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100561209 | CMS |
| Novo Nordisk Inc | $19.24 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100327814 | CMS |
| Novo Nordisk Inc | $14.75 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100361037 | CMS |
| Novo Nordisk Inc | $19.23 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100269720 | CMS |
| PFIZER INC. | $16.65 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131790165 | CMS |
| PFIZER INC. | $17.91 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142664126 | CMS |
| Sumitomo Pharma America, Inc. | $18.06 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148980481 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.